Adverse Drug Reaction Monitoring of Semaglutide in India: Impact of Expanding Formulations and Generic Market Entry
Semaglutide has become a key therapy for the management of Type 2 Diabetes Mellitus and obesity. In India, the rising burden of metabolic diseases has led to a rapid increase in its use. Recently, with the expiry of patent protection, generic semaglutide has been officially introduced in the…...
10.5281/zenodo.20951128